These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31274144)

  • 1. Identification and Quantification of 5-Fluoro ADB and the 5-Fluoro ADB Ester Hydrolysis Metabolite in Postmortem Blood Samples by LC-MS/MS.
    Seither JZ; Reidy LJ; Boland DM
    J Anal Toxicol; 2020 Mar; 44(2):133-139. PubMed ID: 31274144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forty-Three Fatalities Involving the Synthetic Cannabinoid, 5-Fluoro-ADB: Forensic Pathology and Toxicology Implications.
    Boland DM; Reidy LJ; Seither JM; Radtke JM; Lew EO
    J Forensic Sci; 2020 Jan; 65(1):170-182. PubMed ID: 31211877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
    Yeter O; Erol Öztürk Y
    Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 5-Fluoro ADB in Human Whole Blood in Four Death Cases.
    Usui K; Fujita Y; Kamijo Y; Kokaji T; Funayama M
    J Anal Toxicol; 2018 Mar; 42(2):e21-e25. PubMed ID: 29186561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
    Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
    Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Driving Associated with the Synthetic Cannabinoid 5f-Adb.
    McCain KR; Jones JO; Chilbert KT; Patton AL; James LP; Moran JH
    J Forensic Sci Criminol; 2018 Aug; 6(1):. PubMed ID: 30956998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an enzyme-linked immunosorbent assay screening method and a liquid chromatography-tandem mass spectrometry confirmation method for the identification and quantification of ketamine and norketamine in urine samples from Malaysia.
    Harun N; Anderson RA; Miller EI
    J Anal Toxicol; 2009; 33(6):310-21. PubMed ID: 19653934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver.
    Hasegawa K; Wurita A; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Watanabe K; Suzuki O
    Forensic Toxicol; 2015; 33(2):380-387. PubMed ID: 26257834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of synthetic cannabinoid FUB-AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC-MS/MS.
    Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
    Biomed Chromatogr; 2020 Sep; 34(9):e4884. PubMed ID: 32415732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Synthetic Cannabinoid ADB-BUTINACA-Related Death of a Police Dog.
    Tokarczyk B; Suchan M; Adamowicz P
    J Anal Toxicol; 2023 Mar; 47(2):e23-e28. PubMed ID: 36472351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.